TickerGuard
Buy Day today: Neutral (55) Mixed market breadth · no major macro event
CGC

Canopy Growth Corp

Healthcare · Drug Manufacturers - Specialty & Generic

0.8468$ -3.4% vs. previous close Closing price · As of: Oct 8, 2026

Statements

Income Statement

Canopy Growth Corp (CGC) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 81 million CAD. Tick rows to compare them in a chart.

All figures in millions of CAD.

Tick rows to compare them in a chart (up to 4)

Income Statement CGC
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
8.5 9.8 15 16 18 22 23 26 23 83 94 90 77 124 108 110 135 153 148 136 131 141 112 106 88 85 74 76 70 79 73 66 63 75 65 72 67 102 71 81 321
-7.3 -7.2 13 -3.8 -11 3.1 16 -16 57 71 26 -16 73 86 314 104 109 128 139 109 203 131 271 112 89 80 178 62 46 50 57 43 41 51 54 54 45 73 63 59 240
16 17 1.4 18 27 17 7.2 42 -34 16 68 106 3.6 38 -206 6.5 26 25 9.8 27 -71 10 -159 -5.6 -0.6 5.2 -104 14 23 28 15 23 22 24 11 18 22 29 8.3 22 82
0.5 0.4 0.5 0.1 0.5 0.3 0.5 0.8 1.9 5.3 7.3 8.5 12 21 21 14 14 14 16 8.3 8.8 6.5 8.7 7.0 5.5 4.9 4.4 1.4 1.1 1.3 0.8 – – – 2.7 – – – – – –
5.0 5.5 11 12 15 29 37 50 133 110 159 150 181 129 165 96 92 72 70 47 51 34 44 34 40 37 35 29 23 28 24 23 22 22 6.4 15 16 19 15 34 84
22 12 23 22 28 43 58 73 173 173 243 216 274 231 903 179 310 578 243 215 144 160 370 1,837 149 118 576 68 30 89 122 52 68 48 15 41 39 66 36 44 184
-6.1 4.8 -22 -4.2 -1.0 -26 -51 -60 -215 -157 -174 -123 -277 -192 -1,109 -172 -284 -554 -233 -188 -215 -150 -530 -1,842 -149 -113 -680 -55 -7.0 -60 -107 -29 -46 -24 -4.4 -23 -17 -36 -27 -22 -103
0.0 0.2 0.2 0.0 0.1 0.2 24 16 0.5 1.0 0.7 1.2 1.2 2.2 2,480 1.2 1.5 1.0 4.8 25 27 26 21 27 30 33 36 32 27 25 21 21 21 17 15 9.7 8.8 10 12 13 44
5.8 3.7 -22 -7.8 -0.9 19 -62 -94 -330 76 -310 -1,267 237 -137 280 -131 -96 -845 -612 393 -20 -116 -587 -2,088 -188 -228 -740 -8.6 -135 -231 -96 -123 -131 -122 -221 -41 -1.4 -85 -158 -15 -260
0.4 0.7 -1.3 1.3 0.7 7.6 -8.0 -2.7 0.3 -1.0 14 14 -5.8 -27 -113 -3.0 0.6 -16 4.9 2.9 -3.2 -0.2 -8.5 3.7 8.2 -1.3 -16 2.0 13 -1.1 -1.4 6.2 0.3 0.3 0.3 0.3 0.2 0.5 -0.9 -0.1 -0.3
5.4 3.0 -21 -6.0 -1.3 1.6 -62 -80 -337 68 -336 -1,283 259 -91 457 -109 -32 -904 -700 392 -11 -109 -575 -2,086 -292 -259 -712 -38 -310 -217 -92 -127 -128 -122 -221 -42 -1.6 -86 -157 -15 -259
7.5 7.2 -12 1.7 5.2 -20 -45 -54 -183 -145 -198 -181 263 -104 -920 -96 -63 -811 -578 443 36 -59 -530 -2,039 -138 -176 -683 41 -95 -194 -64 -91 -100 -95 -194 -22 17 -63 -137 -4.7 -188

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?